Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
BackgroundVonoprazan fumarate is a potassium-competitive acid blocker that was developed as a novel acid-suppressing drug for multiple indications. As a potential alternative to proton-pump inhibitors, the determination of the drug-drug interactions is vital for further applications. Probe drug cock...
Saved in:
Main Authors: | Yiran Wang (Author), Changxiong Wang (Author), Shuanghu Wang (Author), Quan Zhou (Author), Dapeng Dai (Author), Jihua Shi (Author), Xue Xu (Author), Qingfeng Luo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo
by: Yiran Wang, et al.
Published: (2022) -
Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
by: Jinhui Wang, et al.
Published: (2021) -
Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo
by: Shan Zhou, et al.
Published: (2023) -
The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018) -
In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
by: Alexander V. Dmitriev, et al.
Published: (2021)